Cholangiocarcinoma
📧 Sign up to get email alerts when something new happens for Cholangiocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers [Phase 1, Phase 2]
The document describes an ongoing Phase 1/2 trial evaluating tivozanib for biliary tract cancers and is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Y-90 With Durvalumab/Gem/Cis in Intrahepatic Cholangio [Phase 2]
Phase 2 clinical trial evaluating Yttrium-90 radioembolization combined with durvalumab, gemcitabine, and cisplatin for intrahepatic cholang…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer
The update details a study to collect solid tumor tissue from people undergoing biopsy or surgery for colorectal, gastric, cholangiocarcinom…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Study of PHST001 in Advanced Solid Tumors [Phase 1]
Pheast Therapeutics is recruiting for a Phase 1 study of PHST001 in patients with advanced solid tumors, including ovarian cancer, endometri…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer
Clinical trial update on a precision-based immunotherapy program for primary liver cancer, currently active but not recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Study of LY4337713 in Participants With FAP-Positive Solid Tumors [Phase 1]
A Phase 1 clinical trial update for LY4337713 in participants with FAP-positive solid tumors; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Molecular Epidemiology of Biliary Tree Cancers
This ClinicalTrials.gov study update notes that a trial on the molecular epidemiology of biliary tree cancers is currently recruiting, led b…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver Function [Phase 1]
Phase 1 study evaluating radiation therapy for patients with hepatocellular carcinoma, cholangiocarcinoma, or liver metastases who have impa…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Agnostic Therapy in Rare Solid Tumors [Phase 2]
A Phase 2 trial of an agnostic therapy for multiple rare solid tumors is currently recruiting. The study lists a broad set of tumor types ac…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study to Determine Whether Chemotherapy and Atezolizumab is Better Than Chemotherapy, Bevacizumab and Atezolizumab in Patients With Advanced Liver Cancer [Phase 2]
This Phase 2 trial evaluates whether chemotherapy with atezolizumab is superior to chemotherapy with bevacizumab and atezolizumab in patient…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Clinical Effectiveness of Microwave Ablation Using Starwave Microwave Generator for Hepatic Malignancies [NA]
A clinical trial update indicates a study evaluating microwave ablation with the Starwave Microwave Generator for hepatic malignancies is cu…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: MP0317 in Combination With Chemoimmunotherapy in First Line Treatment for Patients With Advanced Biliary Tract Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating MP0317 in combination with chemoimmunotherapy as first-line treatment for advanced biliary tract carcino…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Combined Treatment of Durvalumab, Bevacizumab, Tremelimumab and Transarterial Chemoembolization (TACE) in Subjects With Hepatocellular Carcinoma or Biliary Tract Carcinoma [Phase 2]
This update describes a Phase 2 trial evaluating durvalumab, bevacizumab, tremelimumab plus transarterial chemoembolization for hepatocellul…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Phase II Study Evaluating Ivosidenib Maintenance After SOC Adjuvant Chemotherapy in Curative mIDH1 Cholangiocarcinoma [Phase 2]
Phase II study evaluating maintenance therapy with ivosidenib after standard-of-care adjuvant chemotherapy in curative IDH1-mutant cholangio…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies [Phase 4]
Phase 4 trial evaluating olutasidenib for drug-drug interaction in IDH1-mutant malignancies. The study is currently recruiting in AML, gliom…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab
Clinical trial update describing investigation of predictive biomarkers in patients with advanced biliary tract cancer treated with lenvatin…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Vebotolimab Combined With Ptorlimab for EGFR-positive Refractory Advanced Biliary Tract Malignancies [Phase 2]
A Phase 2 clinical trial evaluating the combination of vebotolimab and Ptorlimab for EGFR-positive advanced biliary tract cancers is not yet…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: FAPI-PET Value for the Initial Screening of Pancreatic and Biliary Cancers [Phase 2]
A Phase 2 study investigating the use of FAPI-PET imaging for initial screening of cholangiocarcinoma and pancreatic adenocarcinoma, status …
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Liquid Biopsy MonitORing Of CholangioCarcinOma for Treatment Response and Prognostic Outcomes (MOROCCO)
A Mayo Clinic study named MOROCCO is evaluating liquid biopsy-based monitoring to assess treatment response and prognosis in cholangiocarcin…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Detecting Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma (LyMIC)
A completed clinical trial (LyMIC) studying detection of lymph node metastasis in intrahepatic cholangiocarcinoma. The trial was sponsored b…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: A Clinical Study of TQB3454 Tablets in the Treatment of Advanced Biliary Carcinoma. [Phase 3]
Phase 3 clinical trial update for TQB3454 in advanced biliary carcinoma (cholangiocarcinoma), with status ACTIVE_NOT_RECRUITING.
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: 18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant [Phase 1]
This clinical trial update describes a Phase 1 imaging study using 18F-FSPG PET to evaluate liver cancer in patients scheduled for liver res…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
An ongoing clinical trial is recruiting to study the frequency and clinical phenotype of BAP1 tumor predisposition syndrome and its associat…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: TRACE-BTC. Relation of Biomarkers and Patients Reported Quality of Life to Outcomes in Patients With Biliary Tract Cancer: a Real- World Cohort
The TRACE-BTC study is a real-world cohort investigation examining how biomarkers and patient-reported quality of life relate to outcomes in…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01) [Phase 3]
A Phase 3 trial evaluating rilvegostomig combined with chemotherapy as adjuvant therapy after surgical resection for biliary tract cancer is…